EP2494983 - Bibliographic data
FORMULATION STABLE DE GLP-1
| Last update | 09/07/2025 |
|---|---|
| Legal status | Brevet déchu |
| Origin | Européen |
| (73) Holder |
Novo Nordisk A/S Novo Allé
2880 Bagsværd
Danemark
|
|---|---|
| (72) Inventors |
Svend Ludvigsen Novo Nordisk A/S
Baunedalen 13
3540 Lynge
Danemark
Morten Schlein Novo Nordisk A/S
Under Elmene 16, 4. tv.
2300 København S
Danemark
Tine Elisabeth Gottschalk Bøving Novo Nordisk A/S
Boveskovvej 4
2800 Lyngby
Danemark
Claude Bonde Novo Nordisk A/S
Borgevej 41 B
2800 Lyngby
Danemark
Anne-Mette Lilleøre Novo Nordisk A/S
Schioldannsvej 1, 1. sal
2920 Charlottenlund
Danemark
Dorthe Kot Engelund Novo Nordisk A/S
Gassehaven 39
2840 Holte
Danemark
Bjarne Rønfeldt Nielsen Novo Nordisk A/S
Ligustervænget 27
2830 Virum
Danemark
|
| (74) Agent |
Mail recipient Potter Clarkson Chapel Quarter
Mount Street
Nottingham NG1 6HQ
Royaume-Uni
|
| (21) Request number | EP12153063.8 |
|---|---|
| (22) Request date | 14/11/2005 |
| (11) Publication number | EP2494983 |
|---|---|
| Publication date | 24/04/2019 |
| (54) Title of the invention | FORMULATION STABLE DE GLP-1 |
|---|---|
| (51) International classification | A61K 38/26, A61K 47/10, A61K 47/26, A61P 3/10 |
| International classification (before reform) | None |
| Claimed priority |
(31) Number: 200401753 |
|---|---|
| Initial application | None |
| Divisional application | None |
| Expected annuity |
Annuity: 15 -
Amount: 340 € -
Due date 02/12/2019
Surtax: 15 - Amount: 68 € - Due date 03/06/2020 |
|---|---|
| Last annuity | None |
| Publication | None |
|---|---|
| History | Publication de la délivrance du brevet européen - Legal date 24/04/2019 Entrée en période de grâce du brevet d'invention - Legal date 03/12/2019 Modification du mandataire OEB du brevet européen - Legal date 28/02/2020 Déchéance du brevet d'invention après période de grâce - Legal date 02/12/2019 Révocation du brevet européen - Legal date 01/07/2021 |